Children's Hospital Los Angeles (CHLA) · 2 weeks ago
Fellow-Post Doc-Research / HemOnc / Dr. Asgharzadeh's Lab / Full-time / Days
Children's Hospital Los Angeles (CHLA) is a top-ranked pediatric hospital that provides exceptional care for children. They are seeking a postdoctoral fellow to investigate novel CAR T-cell therapies and other immunotherapies in preclinical models of childhood neuroblastoma, contributing to significant research in the field of pediatric oncology.
Health Care
Responsibilities
Investigate novel CAR T-cell therapies and other immunotherapies in preclinical models of childhood neuroblastoma
Perform laboratory work and conduct research activities independently or in collaboration with the Principal Investigator
Publish results in scientific manuscripts and research publications
Participate in seminars, meetings, trainings and other educational sessions
Qualification
Required
MD and/or PhD, or equivalent doctoral degree
Applicants must have completed their doctoral degree by their anticipated start date
Strong background in immunology and molecular biology
Preferred
Exposure to and/or experience in research in a healthcare environment
Company
Children's Hospital Los Angeles (CHLA)
Here at CHLA, we believe every child deserves to enjoy all those special moments that childhood has to offer, free from pain and suffering.
H1B Sponsorship
Children's Hospital Los Angeles (CHLA) has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (24)
2024 (36)
2023 (30)
2022 (30)
2021 (22)
2020 (22)
Funding
Current Stage
Late StageTotal Funding
$39.4MKey Investors
ERK FoundationHyundai Hope On WheelsCalifornia Institute for Regenerative Medicine
2025-09-03Grant
2024-08-28Grant· $0.4M
2024-03-01Grant· $6M
Leadership Team
Recent News
2025-12-19
Company data provided by crunchbase